X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-15 | ASTC | Astrotech Corp | McFarland Robert N | Dir | P - Purchase | $8.50 | +1,185 | 10,900 | +12% | +$10,073 | ||||||
M | 2024-03-13 | ASTC | Astrotech Corp | Becker James Frank | Dir | P - Purchase | $8.20 | +1,488 | 14,087 | +12% | +$12,200 | |||||
2024-03-13 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale | $4.94 | -7,500 | 224,368 | -3% | -$37,035 | ||||||
2024-03-12 | ASTC | Astrotech Corp | Russler Daniel T Jr | Dir | P - Purchase | $8.29 | +500 | 14,517 | +4% | +$4,145 | ||||||
2024-03-13 | WAT | Waters Corp /de/ | Baddour Linda | Dir | S - Sale | $355.54 | -500 | 2,250 | -18% | -$177,770 | ||||||
2024-03-13 | ASTC | Astrotech Corp | Wilkinson Thomas Wiley | Dir | P - Purchase | $8.28 | +1,300 | 19,753 | +7% | +$10,765 | ||||||
2024-03-12 | ASTC | Astrotech Corp | Becker James Frank | Dir | P - Purchase | $8.14 | +958 | 12,599 | +8% | +$7,798 | ||||||
2024-03-07 | SEER | Seer, Inc. | Farokhzad Omid | CEO, CHAIR | S - Sale | $2.03 | -52,857 | 1,436,285 | -4% | -$107,421 | ||||||
2024-03-08 | AVTR | Avantor, Inc. | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $25.63 | -3,685 | 34,406 | -10% | -$94,447 | ||||||
2024-03-08 | A | Agilent Technologies, Inc. | McMullen Michael R. | CEO, Pres | S - Sale | $150.00 | -52,297 | 253,909 | -17% | -$7,844,550 | ||||||
M | 2024-03-08 | NAUT | Nautilus Biotechnology, Inc. | Patel Sujal M | CEO, Pres,, Secretary, 10% | P - Purchase | $2.87 | +14,474 | 17,158,999 | 0% | +$41,478 | |||||
2024-03-07 | A | Agilent Technologies, Inc. | Gonsalves Rodney | VP, Corporate Controller | S - Sale | $149.00 | -4,828 | 21,370 | -18% | -$719,348 | ||||||
M | 2024-03-05 | NAUT | Nautilus Biotechnology, Inc. | Patel Sujal M | CEO, Pres,, Secretary, 10% | P - Purchase | $2.79 | +35,526 | 17,144,525 | 0% | +$99,054 | |||||
2024-03-05 | A | Agilent Technologies, Inc. | Fields Heidi | Dir | S - Sale | $144.34 | -1,658 | 54,976 | -3% | -$239,316 | ||||||
M | 2024-03-04 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.57 | +251,403 | 23,093,703 | +1% | +$646,169 | |||||
2024-03-06 | PACB | Pacific Biosciences of California, Inc. | Meline David W | Dir | P - Purchase | $4.40 | +40,000 | 40,000 | New | +$176,160 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $4.87 | -2,968 | 217,216 | -1% | -$14,457 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $4.87 | -9,186 | 1,668,826 | -1% | -$44,745 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Kim Susan G. | See Remarks | S - Sale | $4.87 | -5,275 | 712,260 | -1% | -$25,695 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $4.87 | -14,177 | 2,596,670 | -1% | -$69,056 | ||||||
2024-03-04 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $44.00 | -4,660 | 1,043,467 | 0% | -$205,021 | ||||||
D | 2024-03-04 | BRKR | Bruker Corp | Requardt Hermann Fritz | Dir | S - Sale+OE | $90.06 | -15,000 | 23,147 | -39% | -$1,350,898 | |||||
D | 2024-03-04 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,278.73 | -400 | 734 | -35% | -$511,492 | |||||
2024-02-29 | AVTR | Avantor, Inc. | Bramwell James | EVP Sales, Customer Excellence | S - Sale | $24.52 | -4,910 | 96,233 | -5% | -$120,393 | ||||||
2024-02-29 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, AMEA | S - Sale | $24.53 | -13,074 | 83,889 | -13% | -$320,705 | ||||||
D | 2024-02-28 | BRKR | Bruker Corp | Busse Falko | Pres, BioSpin Group | S - Sale+OE | $85.48 | -28,122 | 32,859 | -46% | -$2,403,890 | |||||
D | 2024-02-28 | BIOBI | Bio-Rad Laboratories, Inc. | Ernst Timothy S | EVP, GC, Sec | S - Sale+OE | $330.55 | -2,500 | 3,397 | -42% | -$826,375 | |||||
D | 2024-02-27 | RVTY | Revvity, Inc. | Vohra Tajinder S | Please See Remarks | S - Sale+OE | $105.39 | -7,918 | 26,113 | -23% | -$834,441 | |||||
D | 2024-02-27 | BIOBI | Bio-Rad Laboratories, Inc. | Crowley Michael | EVP, GBL Commercial Operations | S - Sale+OE | $336.00 | -3,000 | 6,942 | -30% | -$1,008,000 | |||||
D | 2024-02-26 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $0.96 | -350 | 27,007 | -1% | -$336 | |||||
D | 2024-02-27 | AVTR | Avantor, Inc. | Bramwell James | EVP Sales, Customer Excellence | S - Sale+OE | $24.49 | -6,203 | 101,143 | -6% | -$151,911 | |||||
D | 2024-02-23 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,210.83 | -300 | 4,914 | -6% | -$363,249 | |||||
2024-02-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $46.34 | -2,821 | 1,048,127 | 0% | -$130,737 | ||||||
2024-02-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $46.34 | -2,613 | 283,059 | -1% | -$121,098 | ||||||
2024-02-22 | TXG | 10X Genomics, Inc. | McAnear Justin J. | CFO | S - Sale | $46.34 | -1,865 | 95,240 | -2% | -$86,432 | ||||||
2024-02-23 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale | $105.13 | -835 | 104,609 | -1% | -$87,784 | ||||||
2024-02-23 | RVTY | Revvity, Inc. | Singh Prahlad R. | Please See Remarks | S - Sale | $105.13 | -1,144 | 127,358 | -1% | -$120,269 | ||||||
D | 2024-02-22 | BRKR | Bruker Corp | Prause Burkhard | Pres, CEO, BRUKER BEST | S - Sale+OE | $83.30 | -15,319 | 17,065 | -47% | -$1,276,073 | |||||
2024-02-22 | ILMN | Illumina, Inc. | Thaysen Jacob | CEO | P - Purchase | $135.29 | +7,330 | 14,861 | +97% | +$991,672 | ||||||
D | 2024-02-22 | SEER | Seer, Inc. | Kogan Elona | GC | S - Sale+OE | $1.58 | -12,684 | 273,142 | -4% | -$20,024 | |||||
D | 2024-02-22 | SEER | Seer, Inc. | Horn David R. | Pres, CFO | S - Sale+OE | $1.58 | -12,684 | 480,511 | -3% | -$20,024 | |||||
2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $5.96 | -33,560 | 876,611 | -4% | -$199,950 | ||||||
2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Eidel Jeff | See Remarks | S - Sale | $5.96 | -15,498 | 432,032 | -3% | -$92,337 | ||||||
M | 2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Kim Susan G. | See Remarks | S - Sale | $5.93 | -23,327 | 282,758 | -8% | -$138,403 | |||||
M | 2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $5.94 | -81,017 | 1,005,078 | -7% | -$481,320 | |||||
2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $5.96 | -7,562 | 101,164 | -7% | -$45,054 | ||||||
2024-02-15 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $48.87 | -5,000 | 1,050,948 | 0% | -$244,332 | ||||||
2024-02-14 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale | $24.35 | -1,500 | 15,238 | -9% | -$36,525 | ||||||
D | 2024-02-12 | MTD | Mettler Toledo International Inc/ | Finney Elisha W | Dir | S - Sale+OE | $1,177.35 | -251 | 316 | -44% | -$295,515 | |||||
D | 2024-02-12 | MTD | Mettler Toledo International Inc/ | Kelly Michael A | Dir | S - Sale+OE | $1,175.00 | -1,268 | 1,677 | -43% | -$1,489,896 | |||||
2024-02-09 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $49.53 | -1,000 | 1,055,948 | 0% | -$49,530 | ||||||
2024-02-05 | SEER | Seer, Inc. | Horn David R. | Pres, CFO | S - Sale | $1.67 | -3,608 | 328,157 | -1% | -$6,015 | ||||||
D | 2024-02-05 | RVTY | Revvity, Inc. | Singh Prahlad R. | Please See Remarks | S - Sale+OE | $104.28 | -21,217 | 128,502 | -14% | -$2,212,480 | |||||
D | 2024-02-05 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale+OE | $104.28 | -15,475 | 105,444 | -13% | -$1,613,697 | |||||
D | 2024-02-02 | EYPT | Eyepoint Pharmaceuticals, Inc. | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $28.49 | -209 | 37,962 | -1% | -$5,954 | |||||
D | 2024-02-01 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $1.30 | -494 | 76,707 | -1% | -$642 | |||||
D | 2024-01-26 | EYPT | Eyepoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $25.66 | -49,325 | 36,505 | -57% | -$1,265,539 | |||||
D | 2024-01-26 | EYPT | Eyepoint Pharmaceuticals, Inc. | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $25.38 | -26,017 | 37,962 | -41% | -$660,370 | |||||
D | 2024-01-25 | EYPT | Eyepoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $25.00 | -600 | 36,505 | -2% | -$15,000 | |||||
D | 2023-12-20 | SCND | Scientific Industries Inc | Moore John A | Dir | P - Purchase | $2.00 | +2,030 | 398,290 | +1% | +$4,060 | |||||
D | 2023-12-19 | SCND | Scientific Industries Inc | Moore John A | Dir | P - Purchase | $2.00 | +20,400 | 394,230 | +5% | +$40,800 | |||||
D | 2023-12-13 | SCND | Scientific Industries Inc | Moore John A | Dir | P - Purchase | $2.00 | +26,100 | 353,430 | +8% | +$52,200 | |||||
D | 2024-01-17 | SCND | Scientific Industries Inc | Santos Helena R | CEO, Pres | P - Purchase | $2.00 | +11 | 258,288 | 0% | +$22 | |||||
DM | 2024-01-24 | EYPT | Eyepoint Pharmaceuticals, Inc. | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $25.01 | -11,900 | 37,962 | -24% | -$297,621 | |||||
DM | 2024-01-23 | EYPT | Eyepoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $25.01 | -16,386 | 36,505 | -31% | -$409,790 | |||||
DM | 2024-01-23 | EYPT | Eyepoint Pharmaceuticals, Inc. | Lurker Nancy | Exec Vice Chair | S - Sale+OE | $24.98 | -35,000 | 187,649 | -16% | -$874,200 | |||||
D | 2024-01-23 | AXDX | Accelerate Diagnostics, Inc | Strobeck Matthew | Dir | P - Purchase | $0.00 | +100,000 | 325,238 | +44% | +$0 | |||||
D | 2024-01-23 | AXDX | Accelerate Diagnostics, Inc | Francesconi Louise | Dir | P - Purchase | $0.00 | +13,333 | 20,927 | +176% | +$0 | |||||
D | 2024-01-23 | AXDX | Accelerate Diagnostics, Inc | Massarany Hany | Dir | P - Purchase | $0.00 | +16,666 | 27,260 | +157% | +$0 | |||||
D | 2024-01-23 | AXDX | Accelerate Diagnostics, Inc | Patience John | Dir | P - Purchase | $0.00 | +16,666 | 671,211 | +3% | +$0 | |||||
DM | 2024-01-22 | EYPT | Eyepoint Pharmaceuticals, Inc. | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $22.68 | -35,066 | 37,962 | -48% | -$795,191 | |||||
2024-01-16 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $45.24 | -4,000 | 1,056,948 | 0% | -$180,956 | ||||||
D | 2023-12-13 | SCND | Scientific Industries Inc | Frampton Marcus | 10% | P - Purchase | $2.00 | +27,530 | 135,683 | +25% | +$55,060 | |||||
2024-01-11 | EYEP | Eyepoint Pharmaceuticals, Inc. | Ocumension Therapeutics | Dir | S - Sale | $19.45 | -1,910,500 | 100,221 | -95% | -$37,159,225 | ||||||
2024-01-11 | EYPT | Eyepoint Pharmaceuticals, Inc. | Liu Ye | Dir | S - Sale | $19.45 | -1,910,500 | 100,221 | -95% | -$37,159,225 | ||||||
M | 2024-01-09 | EYPT | Eyepoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $19.94 | +855,000 | 6,893,235 | +14% | +$17,051,100 | |||||
2024-01-09 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $7.77 | -31,012 | 910,171 | -3% | -$241,056 | ||||||
D | 2024-01-08 | EYPT | Eyepoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $21.13 | -22,913 | 36,505 | -39% | -$484,124 | |||||
D | 2024-01-02 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale+OE | $26.91 | -1,000 | 16,738 | -6% | -$26,910 | |||||
M | 2023-12-27 | ASTC | Astrotech Corp | McFarland Robert N | Dir | P - Purchase | $8.19 | +1,221 | 9,715 | +14% | +$10,003 | |||||
2023-12-27 | A | Agilent Technologies, Inc. | Binns Philip | SVP | S - Sale | $139.78 | -2,880 | 12,824 | -18% | -$402,566 | ||||||
2023-12-26 | CTKB | Cytek Biosciences, Inc. | Jeanmonod Patrik | CFO | S - Sale | $9.50 | -3,000 | 93,400 | -3% | -$28,500 | ||||||
2023-12-19 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $9.43 | -20,000 | 6,042,103 | 0% | -$188,600 | ||||||
D | 2023-12-19 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $4.48 | -7,500 | 152,563 | -5% | -$33,566 | |||||
M | 2023-12-15 | LCTC | Lifeloc Technologies, Inc | Willkomm Wayne | CEO, Pres | P - Purchase | $2.23 | +1,625 | 26,302 | +7% | +$3,631 | |||||
2023-12-18 | A | Agilent Technologies, Inc. | Gonsalves Rodney | VP, Corporate Controller | S - Sale | $137.69 | -1,500 | 26,173 | -5% | -$206,538 | ||||||
D | 2023-12-15 | A | Agilent Technologies, Inc. | Ancher-Jensen Henrik | SVP | S - Sale+OE | $138.36 | -26,331 | 82,504 | -24% | -$3,643,157 | |||||
2023-12-14 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $55.03 | -2,000 | 1,046,013 | 0% | -$110,065 | ||||||
D | 2023-12-13 | EYPT | Eyepoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | S - Sale+OE | $20.00 | -1,458 | 25,707 | -5% | -$29,160 | |||||
D | 2023-12-13 | A | Agilent Technologies, Inc. | McMullen Michael R. | CEO, Pres | S - Sale+OE | $130.00 | -2,751 | 306,206 | -1% | -$357,630 | |||||
D | 2023-12-13 | SCND | Scientific Industries Inc | Bleichroeder LP | 10% | P - Purchase | $2.00 | +600,000 | 1,203,351 | +99% | +$1,200,000 | |||||
2023-12-14 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $10.00 | -20,000 | 1,086,095 | -2% | -$200,000 | ||||||
D | 2023-12-13 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $4.39 | -739 | 59,535 | -1% | -$3,244 | |||||
D | 2023-12-13 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $4.39 | -97 | 9,691 | -1% | -$426 | |||||
D | 2023-12-12 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $4.25 | -7,500 | 152,563 | -5% | -$31,871 | |||||
2023-12-11 | ASTC | Astrotech Corp | Russler Daniel T Jr | Dir | P - Purchase | $7.65 | +650 | 14,017 | +5% | +$4,973 | ||||||
2023-12-12 | BIOBI | Bio-Rad Laboratories, Inc. | Wright Dara | EVP, Pres, CDG | S - Sale | $299.16 | -1,200 | 1,499 | -44% | -$358,992 | ||||||
2023-12-08 | EYPT | Eyepoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $17.00 | +588,235 | 6,038,235 | +11% | +$9,999,995 | ||||||
AD | 2023-12-04 | EYPT | Eyepoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev., Strat. Office | S - Sale+OE | $21.97 | -46,000 | 4,343 | -91% | -$1,010,790 | |||||
D | 2023-12-07 | A | Agilent Technologies, Inc. | McMullen Michael R. | CEO, Pres | S - Sale+OE | $130.00 | -62,467 | 306,206 | -17% | -$8,120,710 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |